2025-04-012026-03-312026-03-31false08275931SOUTH LONDON PATHOLOGY LTD.2026-10-0186220falseiso4217:GBPxbrli:pure082759312025-03-31082759312026-03-31082759312025-04-012026-03-31082759312024-03-31082759312025-03-31082759312024-04-012025-03-3108275931bus:Micro-entities2025-04-012026-03-3108275931bus:AuditExempt-NoAccountantsReport2025-04-012026-03-3108275931bus:FullAccounts2025-04-012026-03-3108275931bus:PrivateLimitedCompanyLtd2025-04-012026-03-3108275931core:WithinOneYear2026-03-3108275931core:AfterOneYear2026-03-3108275931core:WithinOneYear2025-03-3108275931core:AfterOneYear2025-03-3108275931dpl:CostSales2025-04-012026-03-3108275931dpl:AdministrativeExpenses2025-04-012026-03-3108275931dpl:DistributionCosts2025-04-012026-03-3108275931dpl:CostSales2024-04-012025-03-3108275931dpl:AdministrativeExpenses2024-04-012025-03-3108275931dpl:DistributionCosts2024-04-012025-03-3108275931core:WithinOneYear2026-03-3108275931core:AfterOneYear2026-03-3108275931core:WithinOneYear2025-03-3108275931core:AfterOneYear2025-03-3108275931core:WithinOneYear2025-04-012026-03-3108275931core:AfterOneYear2025-04-012026-03-3108275931bus:Director12025-04-012026-03-3108275931bus:Director22025-04-012026-03-31

SOUTH LONDON PATHOLOGY LTD.

Registered Number
08275931
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2026

SOUTH LONDON PATHOLOGY LTD.
Company Information
for the year from 1 April 2025 to 31 March 2026

Directors

WOTHERSPOON, Andrew Charles, Dr
WOTHERSPOON, Claire

Company Secretary

CAPITAX & CO. (TAX CONSULTANTS) LTD.

Registered Address

C/O Capitax & Co (Tax Consultants) Ltd Cuckoo Wharf
427 Lichfield Road
Birmingham
B6 7SS

Place of Business

261 Amersham Road

Hazelmere

High Wycombe

HP15 7QW


Registered Number

08275931 (England and Wales)
SOUTH LONDON PATHOLOGY LTD.
Balance Sheet as at
31 March 2026

2026
£

2025
£

Assets
Current Assets544,683579,683
544,683579,683
Capital, Reserves and Liabilities
Capital and reserves502,095533,542
Creditors amounts falling due within one year41,15444,617
Accruals and deferred income1,4341,524
544,683579,683
The financial statements were approved and authorised for issue by the Board of Directors on 1 October 2026, and are signed on its behalf by:
WOTHERSPOON, Andrew Charles, Dr
Director
Registered Company No. 08275931